Saint Martin d'Heres, France

Sylvain Lachal

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sylvain Lachal: Innovator in Blood Glucose Regulation

Introduction

Sylvain Lachal is a notable inventor based in Saint Martin d'Heres, France. He has made significant contributions to the field of medical technology, particularly in the regulation of blood glucose levels for patients. His innovative approach combines advanced technology with practical applications to improve patient care.

Latest Patents

Lachal holds a patent for an "Automated system for regulating a patient's blood glucose level." This system includes a blood glucose sensor, an insulin injection device, and a processing and control unit. The unit is capable of predicting the future evolution of a patient's blood glucose over a prediction period. It controls the insulin injection device by taking the prediction into account. The processing and control unit can calibrate the physiological model based on past measurements, calculate an error indicator, and adjust the prediction period accordingly. This invention represents a significant advancement in diabetes management.

Career Highlights

Sylvain Lachal is associated with the Commissariat à l'énergie atomique et aux énergies alternatives, where he applies his expertise in developing innovative solutions for healthcare. His work focuses on integrating technology with medical needs, aiming to enhance the quality of life for patients with diabetes.

Collaborations

Lachal collaborates with talented individuals such as Eléonore Doron and Pierre Jallon. Their combined efforts contribute to the advancement of medical technologies and innovations in their field.

Conclusion

Sylvain Lachal's contributions to blood glucose regulation exemplify the impact of innovation in healthcare. His patented system showcases the potential of technology to improve patient outcomes and represents a significant step forward in diabetes management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…